The Global Fertility Sensor Market fueled by rising consumer demand for sensor-enabled ovulation tracking and conception planning tools. Wearable fertility...
The Global Fertility Sensor Market fueled by rising consumer demand for sensor-enabled ovulation tracking and conception planning tools. Wearable fertility...
Quest Diagnostics and Getlabs strengthen Attunio's AI-powered, biomarker-driven infrastructure with blood and genetic testing from homeATLANTA, June 25, 2026 /PRNewswire/...
RareDAI follows a clinician's chain-of-thought, allowing for reproducibility based on a series of standardized questionsPHILADELPHIA, June 24, 2026 /PRNewswire/ --...
Global awareness campaign highlights the importance of genetic diagnosis in an era of rapidly advancing genetic medicineLOS ANGELES, June 24,...
Now available directly to patients, MyPhenome is the first and only precision obesity test that goes beyond GLP-1 treatment response...
Now available directly to patients, MyPhenome is the first and only precision obesity test that goes beyond GLP-1 treatment response...
DALLAS, June 16, 2026 /PRNewswire/ -- Cizzle Bio, Inc., a Texas-based biotechnology company advancing biomarker blood tests for early detection of...
-- Patients with PWS treated with setmelanotide therapy (N=17) achieved clinically meaningful BMI or BMI z-score reductions, reductions in fat...
Company earns five Golds for its interactive patient education tools, health literacy content, and evidence-based behavioral health appsATLANTA, June 11,...
BOSTON, May 29, 2026 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming...
The move brings Genetic Optimization to one of the most sought-after fertility clinics in the U.S., following Nucleus’ rapid global...
– Real world data showed clinically meaningful BMI reductions with setmelanotide in 62 adults with 12-month data living with acquired...
ALISO VIEJO, Calif.--(BUSINESS WIRE)--Ambry Genetics, a leader in clinical genomic testing, and a wholly owned subsidiary of Tempus AI, Inc....
SALT LAKE CITY, April 30, 2026 (GLOBE NEWSWIRE) -- The latest GeneSight® Mental Health Monitor, a nationwide survey from Myriad...
AI-powered innovation transforms complex genetic data into clear, actionable insights for clinicians and individuals Genomics + AI for Longevity Transforming...
NEWARK, N.J., April 17, 2026 /PRNewswire/ -- Genomic Prediction, Inc., a leader in advanced genetic testing and reproductive genomics, announced...
The program, which has awarded more than $225,000 to help aspiring families access fertility care, kicks off during National Infertility...
Major paradigm shift incorporates five-year risk assessment and identifies increased-risk women beginning at age 35 BOSTON, April 14, 2026 (GLOBE...
ÜNYE, Türkiye, April 09, 2026 (GLOBE NEWSWIRE) -- Çakırtepe Hospital, located on Türkiye’s Black Sea coast in Ünye, has achieved...